platoseedplatoseed
Real-World Data for Health Innovation
Segmed provides at-scale access to novel clinical data globally, offering millions of diagnostic-grade medical images to accelerate innovation and mature the evidence needs of life sciences and technology industry. Our solutions allow you to access a Real World Data (RWD) network to facilitate rapid discovery and investigational capability of imaging data, development of early disease detection & prediction models, improved patient recruitment and reduced operating burden to access therapeutic data ecosystem.
Segmed provides de-identified, regulatory-grade medical imaging data and multimodal real-world data to support AI research and clinical development across life sciences, medical devices, and technology. It offers a platform (Openda) and a global network of healthcare partners to supply imaging datasets for AI training, regulatory submissions, and clinical research.
Segmed aggregates and de-identifies millions of regulatory-grade medical images from a global network of healthcare partners. Its platform offers access to multimodal datasets through subscriptions and data management capabilities, including data de-identification, image data extraction, and imaging data exploration, with a focus on enabling AI training and regulatory-grade validation for FDA/CE compliance.
Who it’s for: Life sciences companies (pharma, biopharma, and biotech), medical device companies, AI/tech firms building healthcare solutions, and clinical researchers requiring regulated, longitudinal imaging data.
Customers: RadUnity, NeuroCare.AI, SaveLife.AI, Aidence
Hiring/traction mentioned via customer deployments and multiple case studies; active partnerships and press releases indicate ongoing growth and market validation
Platform for breakthrough mental health research and treatment
Software for pharmacies to move beyond dispensing
